Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
CBPO CHINA BIOLOGIC PRODUCTS HLDGS INC
0.0000.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2020/09/30(Q2)2020/06/30(Q1)2020/03/31(FY)2019/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-1.75% 569.0594 -9.32% 550.0982 -17.49% 525.3673 -6.34% 579.375
Receivable Turnover(T)
-7.03% 3.7212 -1.07% 4.0286 -4.26% 3.9763 -3.12% 4.4701
Inventory Turnover(T)
3.65% 0.7551 11.72% 0.7705 26.52% 0.8235 9.08% 0.7071
Fixed Assets Turnover(T)
-1.06% 2.8879 5.51% 2.9053 16.74% 3.0248 4.63% 2.8306
Total Asset Rate(T)
-4.49% 0.2551 -13.41% 0.2548 -5.12% 0.2669 -22.95% 0.2552
ROIC
-10.48% 7.429% -15.02% 7.676% -3.49% 7.849% -28.36% 6.983%
ROE
-16.80% 7.864% -17.88% 8.436% -4.61% 8.763% -25.52% 8.024%
ROA
-15.51% 6.913% -13.90% 7.308% -0.20% 7.601% -21.66% 6.946%
FCF to Sales
54.89% 47.455% 106.79% 49.653% 187.60% 47.184% 182.50% 40.677%
FCF to Net Income
76.35% 173.048% 109.99% 171.144% 176.74% 163.861% 181.20% 147.619%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -- -- -21.75% 16.913%
ROA 5 Year Average
-- -- -- -- -- -- -13.92% 12.029%
Average 5 Years ROIC
-- -- -- -- -- -- -17.18% 15.784%
Profitability Ratios TTM
Gross Margin
-2.11% 64.895% -3.90% 64.456% -4.88% 64.211% -4.72% 65.326%
Operating Margin
-2.99% 35.251% 8.86% 35.609% 12.16% 34.999% 3.76% 32.486%
Net Margin
-11.53% 27.094% -0.57% 28.682% 5.19% 28.480% 1.68% 27.220%
EBITDA Margin
-6.22% 0.4391% 4.82% 0.4505% 8.50% 0.4471% 6.73% 0.4333%
R & D Expense Ratio
-3.47% 1.950% 5.63% 2.250% -0.48% 2.080% 14.22% 2.330%
Sales Expense Ratio
-27.59% 11.940% -33.37% 12.660% -26.69% 14.170% -22.13% 15.940%
Administration Expense Rate
37.64% 15.760% 5.29% 13.930% -12.90% 12.960% -1.15% 14.570%
Financial Health Ratios
Total Assets to Common Equity
-0.61% 113.430% -2.93% 113.753% -1.64% 114.329% -2.09% 114.280%
Debt to Asset Ratio
-- -- -- -- -- -- -- 0.069%
Current Ratio
14.72% 12.0126 7.07% 11.3197 -16.70% 10.5136 -1.79% 10.8938
Quick Ratio
21.98% 9.9597 11.69% 9.3268 -11.08% 8.6939 -2.21% 8.6123
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -- -- -15.13% 13.871%
Revenue CAGR(5Y)
-- -- -- -- -- -- -13.33% 15.673%
Net Income CAGR(3Y)
-- -- -- -- -- -- -23.67% 9.828%
Net Income CAGR(5Y)
-- -- -- -- -- -- -22.66% 14.375%
FCF 1 Year Growth
-- -- -- -- -- -- 3,826.23% 204.804%
FCF CAGR(3Y)
-- -- -- -- -- -- 642.97% 41.548%
FCF CAGR(5Y)
-- -- -- -- -- -- 360.81% 23.389%
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist